Barta, Stefan K <br/><br/>
Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia & lymphoma  Oct 2012 
 - 1999-2003 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2012.679267  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antigens, CD19--chemistry<br/>Cell Line, Tumor<br/>Cytarabine--administration & dosage<br/>Disease Models, Animal<br/>Drug Combinations<br/>Drug Synergism<br/>Humans<br/>Immunotoxins--administration & dosage<br/>Mice<br/>Mice, Inbred NOD<br/>Neoplasm Staging<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Ricin--chemistry<br/>Sialic Acid Binding Ig-like Lectin 2--chemistry<br/>Xenograft Model Antitumor Assays